CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of Crohn's disease with Adalimumab in pregnancy – a case report
DOI 10.1055/s-0028-1089871
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Jürgens, J Seiderer, C Tillack, S Brand, S Pfennig, B Göke, T Ochsenkühn
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The fully recombinant human IgG1 antibody adalimumab (Humira, Abbott Laboratories) became an alternative option for treatment of Inflammatory bowel disease. Since many young women in childbearing age are affected by Crohn's disease (CD), it is important to investigate the influences and effects of TNF-α-antibodies regarding the fetal safety. Although infliximab seems to be a safe drug given in conception and p…
Zitieren
Zitierempfehlung
M Jürgens, J Seiderer, C Tillack, S Brand, S Pfennig, B Göke, T Ochsenkühn (2008) Treatment of Crohn's disease with Adalimumab in pregnancy – a case report. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089871
Mit CareLit weiterarbeiten